Nu Skin Enterprises EBIT

The latest EBIT for NUS is $-11M as of June 2026. That compares with $-15M in the prior-year period — up 26.2% year over year. That is below the Consumer Discretionary sector average of $2.9T. Investors often review this figure alongside Nu Skin Enterprises's historical trend and sector peers before judging valuation or financial health.

Over the past year, NUS's EBIT moved from $-15M to $-11M — a 26.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nu Skin Enterprises's operating scale or balance-sheet position.

Against Consumer Discretionary companies, NUS currently prints $-11M for EBIT, while the sector average sits near $2.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nu Skin Enterprises's growth, margins, and balance sheet.

A EBIT figure of $-11M for NUS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Consumer Discretionary average is about $2.9T. Explore the charts below for those layers of context.

After noting NUS's EBIT ($-11M), review year-over-year change from $-15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.